Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Analysis of GNA13 Protein in Follicular Lymphoma and its Association With Poor Prognosis.

Shimono J, Miyoshi H, Yoshida N, Kato T, Sato K, Sugio T, Miyawaki K, Kurita D, Sasaki Y, Kawamoto K, Imaizumi Y, Kato K, Nagafuji K, Akashi K, Seto M, Teshima T, Ohshima K.

Am J Surg Pathol. 2018 Nov;42(11):1466-1471. doi: 10.1097/PAS.0000000000000969.

PMID:
30307409
2.

Primary hepatic carcinosarcoma with multimodal treatment.

Kurita D, Mokuno Y, Matsubara H, Kaneko H, Shamoto M, Satou A, Iyomasa S.

Nagoya J Med Sci. 2018 Aug;80(3):423-429. doi: 10.18999/nagjms.80.3.423.

3.

Expression pattern of immunosurveillance-related antigen in adult T cell leukaemia/lymphoma.

Asano N, Miyoshi H, Kato T, Shimono J, Yoshida N, Kurita D, Sasaki Y, Kawamoto K, Ohshima K, Seto M.

Histopathology. 2018 May;72(6):945-954. doi: 10.1111/his.13461. Epub 2018 Feb 21.

PMID:
29297942
4.

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, Yujiri T, Choi I, Fujimaki K, Muta T, Kume M, Moriguchi S, Tamura S, Kato T, Tagawa H, Makiyama J, Kanisawa Y, Sasaki Y, Kurita D, Yamada K, Shimono J, Sone H, Takizawa J, Seto M, Kimura H, Ohshima K.

Haematologica. 2018 Jun;103(6):1018-1028. doi: 10.3324/haematol.2017.174177. Epub 2017 Dec 14.

5.

Prognostic factors for histiocytic and dendritic cell neoplasms.

Shimono J, Miyoshi H, Arakawa F, Sato K, Furuta T, Muto R, Yanagida E, Sasaki Y, Kurita D, Kawamoto K, Nagafuji K, Ohshima K.

Oncotarget. 2017 Oct 19;8(58):98723-98732. doi: 10.18632/oncotarget.21920. eCollection 2017 Nov 17.

6.

Clinicopathological features of primary splenic follicular lymphoma.

Shimono J, Miyoshi H, Kamimura T, Eto T, Miyagishima T, Sasaki Y, Kurita D, Kawamoto K, Nagafuji K, Seto M, Teshima T, Ohshima K.

Ann Hematol. 2017 Dec;96(12):2063-2070. doi: 10.1007/s00277-017-3139-y. Epub 2017 Oct 3.

PMID:
28975390
7.

Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib.

Iriyama N, Miura K, Hatta Y, Kobayashi S, Uchino Y, Kurita D, Sakagami H, Takahashi H, Sakagami M, Kobayashi Y, Nakagawa M, Ohtake S, Iizuka Y, Takei M.

Oncol Lett. 2017 May;13(5):3803-3808. doi: 10.3892/ol.2017.5920. Epub 2017 Mar 27.

8.

RsgA couples the maturation state of the 30S ribosomal decoding center to activation of its GTPase pocket.

López-Alonso JP, Kaminishi T, Kikuchi T, Hirata Y, Iturrioz I, Dhimole N, Schedlbauer A, Hase Y, Goto S, Kurita D, Muto A, Zhou S, Naoe C, Mills DJ, Gil-Carton D, Takemoto C, Himeno H, Fucini P, Connell SR.

Nucleic Acids Res. 2017 Jun 20;45(11):6945-6959. doi: 10.1093/nar/gkx324.

9.

Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia.

Balan S, Yamada K, Iwayama Y, Hashimoto T, Toyota T, Shimamoto C, Maekawa M, Takagai S, Wakuda T, Kameno Y, Kurita D, Yamada K, Kikuchi M, Hashimoto T, Kanahara N, Yoshikawa T.

Schizophr Res. 2017 Jul;185:33-40. doi: 10.1016/j.schres.2017.01.003. Epub 2017 Jan 7.

PMID:
28073605
10.

Mechanistic insights into the alternative translation termination by ArfA and RF2.

Ma C, Kurita D, Li N, Chen Y, Himeno H, Gao N.

Nature. 2017 Jan 26;541(7638):550-553. doi: 10.1038/nature20822. Epub 2016 Dec 1.

PMID:
27906160
11.

A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.

Kurita D, Takeuchi K, Kobayashi S, Hojo A, Uchino Y, Sakagami M, Ohtake S, Takahashi H, Miura K, Iriyama N, Sugitani M, Miyoshi H, Hatta Y, Ohshima K, Takei M.

Virchows Arch. 2016 Oct;469(4):471-6. doi: 10.1007/s00428-016-1995-9. Epub 2016 Jul 25.

PMID:
27457074
12.

A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma.

Kurita D, Miyoshi H, Yoshida N, Sasaki Y, Kato S, Niino D, Sugita Y, Hatta Y, Takei M, Makishima M, Ohshima K.

Am J Surg Pathol. 2016 Sep;40(9):1249-60. doi: 10.1097/PAS.0000000000000694.

PMID:
27428734
13.

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.

Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, Yokoyama S, Taniguchi H, Sasaki Y, Kurita D, Kawamoto K, Kato K, Imaizumi Y, Seto M, Ohshima K.

Blood. 2016 Sep 8;128(10):1374-81. doi: 10.1182/blood-2016-02-698936. Epub 2016 Jul 14.

14.

Plasma cell maturity as a predictor of prognosis in multiple myeloma.

Iriyama N, Miura K, Hatta Y, Uchino Y, Kurita D, Takahashi H, Sakagami H, Sakagami M, Kobayashi Y, Nakagawa M, Ohtake S, Iizuka Y, Takei M.

Med Oncol. 2016 Aug;33(8):87. doi: 10.1007/s12032-016-0803-3. Epub 2016 Jul 6.

PMID:
27383407
15.

Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.

Takahashi H, Miura K, Nakagawa M, Sugitani M, Amano Y, Kurita D, Sakagami M, Ohtake S, Uchino Y, Kodaira H, Iriyama N, Kobayashi S, Hojo A, Kobayashi Y, Hirabayashi Y, Kusuda M, Hatta Y, Nakayama T, Takei M.

Leuk Lymphoma. 2016 Dec;57(12):2784-2790. Epub 2016 Apr 13.

PMID:
27071312
16.

Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan.

Sasaki Y, Guo Y, Arakawa F, Miyoshi H, Yoshida N, Koga Y, Nakashima K, Kurita D, Niino D, Seto M, Ohshima K.

Hematol Oncol. 2017 Sep;35(3):329-334. doi: 10.1002/hon.2293. Epub 2016 Apr 4.

PMID:
27041734
17.

Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.

Kurita D, Hatta Y, Hojo A, Kura Y, Sawada U, Kanda Y, Takei M.

Cancer Genet. 2016 Apr;209(4):161-5. doi: 10.1016/j.cancergen.2015.12.014. Epub 2016 Jan 11.

PMID:
26854094
18.

CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.

Yoshida N, Miyoshi H, Kato T, Sakata-Yanagimoto M, Niino D, Taniguchi H, Moriuchi Y, Miyahara M, Kurita D, Sasaki Y, Shimono J, Kawamoto K, Utsunomiya A, Imaizumi Y, Seto M, Ohshima K.

J Pathol. 2016 Apr;238(5):621-6. doi: 10.1002/path.4699.

PMID:
26847489
19.

Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.

Miura K, Nakagawa M, Takahashi H, Uchino Y, Kodaira H, Iriyama N, Sakagami M, Ohtake S, Kobayashi S, Hojo A, Kurita D, Kobayashi Y, Kusuda M, Hirabayashi Y, Hatta Y, Takei M.

Int J Hematol. 2016 Mar;103(3):334-40. doi: 10.1007/s12185-015-1926-6. Epub 2015 Dec 29.

PMID:
26715149
20.

Higher Red Blood Cell Distribution Width Is an Adverse Prognostic Factor in Chronic-phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors.

Iriyama N, Hatta Y, Kobayashi S, Uchino Y, Miura K, Kurita D, Kodaira H, Takahashi H, Iizuka Y, Inoue M, Takei M.

Anticancer Res. 2015 Oct;35(10):5473-8.

PMID:
26408711
21.

Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.

Miura K, Takahashi H, Nakagawa M, Izu A, Sugitani M, Kurita D, Sakagami M, Ohtake S, Uchino Y, Hojo A, Kodaira H, Yagi M, Kobayashi Y, Iriyama N, Kobayashi S, Kiso S, Hirabayashi Y, Hatta Y, Takei M.

Leuk Lymphoma. 2016;57(6):1335-41. doi: 10.3109/10428194.2015.1096352. Epub 2015 Oct 22.

PMID:
26390147
22.

Deterioration of clinical features of a patient with autism spectrum disorder after anti-N-methyl-D-aspartate receptor encephalitis.

Kurita D, Wakuda T, Takagai S, Takahashi Y, Iwata Y, Suzuki K, Mori N.

Psychiatry Clin Neurosci. 2015 Aug;69(8):507. doi: 10.1111/pcn.12323. Epub 2015 Jul 1. No abstract available.

23.

Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.

Kurita D, Miura K, Nakagawa M, Ohtake S, Sakagami M, Uchino Y, Takahashi H, Kiso S, Hojo A, Kodaira H, Yagi M, Hirabayashi Y, Kobayashi Y, Iriyama N, Kobayashi S, Hatta Y, Kura Y, Sugitani M, Takei M.

Int J Hematol. 2015 Jun;101(6):585-93. doi: 10.1007/s12185-015-1780-6. Epub 2015 Mar 17.

PMID:
25776837
24.

Ribosome rescue systems in bacteria.

Himeno H, Nameki N, Kurita D, Muto A, Abo T.

Biochimie. 2015 Jul;114:102-12. doi: 10.1016/j.biochi.2014.11.014. Epub 2014 Nov 28. Review.

PMID:
25446863
25.

ArfA recognizes the lack of mRNA in the mRNA channel after RF2 binding for ribosome rescue.

Kurita D, Chadani Y, Muto A, Abo T, Himeno H.

Nucleic Acids Res. 2014 Dec 1;42(21):13339-52. doi: 10.1093/nar/gku1069. Epub 2014 Oct 29.

26.

Rejection of tmRNA·SmpB after GTP hydrolysis by EF-Tu on ribosomes stalled on intact mRNA.

Kurita D, Miller MR, Muto A, Buskirk AR, Himeno H.

RNA. 2014 Nov;20(11):1706-14. doi: 10.1261/rna.045773.114. Epub 2014 Sep 22.

27.

The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia.

Iriyama N, Hatta Y, Kobayashi S, Uchino Y, Miura K, Kurita D, Kodaira H, Inoue M, Takei M.

Int J Hematol. 2014 Oct;100(4):379-85. doi: 10.1007/s12185-014-1649-0. Epub 2014 Aug 5.

PMID:
25092482
28.

Study on dioxygen reduction by mutational modifications of the hydrogen bond network leading from bulk water to the trinuclear copper center in bilirubin oxidase.

Morishita H, Kurita D, Kataoka K, Sakurai T.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):767-72. doi: 10.1016/j.bbrc.2014.06.052. Epub 2014 Jun 19.

PMID:
24952160
29.

tmRNA-mediated trans-translation as the major ribosome rescue system in a bacterial cell.

Himeno H, Kurita D, Muto A.

Front Genet. 2014 Apr 7;5:66. doi: 10.3389/fgene.2014.00066. eCollection 2014. Review.

30.

Mechanism of trans-translation revealed by in vitro studies.

Himeno H, Kurita D, Muto A.

Front Microbiol. 2014 Feb 20;5:65. doi: 10.3389/fmicb.2014.00065. eCollection 2014. Review.

31.

Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.

Kobayashi Y, Hatta Y, Sugitani M, Hojo A, Nakagawa M, Kusuda M, Uchino Y, Takahashi H, Kiso S, Hirabayashi Y, Yagi M, Kodaira H, Kurita D, Miura K, Iriyama N, Kobayashi S, Kura Y, Horikoshi A, Sawada U, Takeuchi J, Takei M.

Leuk Lymphoma. 2014 Nov;55(11):2514-9. doi: 10.3109/10428194.2014.889827. Epub 2014 Mar 17.

PMID:
24491027
32.

Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas.

Iriyama N, Takahashi H, Hatta Y, Miura K, Kobayashi Y, Kurita D, Hirabayashi Y, Hojo A, Kodaira H, Yagi M, Kiso S, Uchino Y, Nakagawa M, Kusuda M, Kobayashi S, Horikoshi A, Kura Y, Yamazaki T, Sawada U, Takeuchi J.

Oncol Rep. 2013 Feb;29(2):805-11. doi: 10.3892/or.2012.2143. Epub 2012 Nov 15.

PMID:
23166041
33.

A case series of Bacillus cereus septicemia in patients with hematological disease.

Uchino Y, Iriyama N, Matsumoto K, Hirabayashi Y, Miura K, Kurita D, Kobayashi Y, Yagi M, Kodaira H, Hojo A, Kobayashi S, Hatta Y, Takeuchi J.

Intern Med. 2012;51(19):2733-8. Epub 2012 Oct 1.

34.

Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP.

Kobayashi Y, Hatta Y, Hojo A, Kura Y, Uchino Y, Takahashi H, Kiso S, Hirabayashi Y, Yagi M, Kodaira H, Kurita D, Tanaka T, Miura K, Iriyama N, Kobayashi S, Sawada U, Sugitani M, Takeuchi J.

Exp Ther Med. 2012 Feb;3(2):304-308. Epub 2011 Nov 22.

35.

In vitro trans-translation assays.

Kurita D, Muto A, Himeno H.

Methods Mol Biol. 2012;905:311-25. doi: 10.1007/978-1-61779-949-5_20.

PMID:
22736013
36.

Liposome-encapsulated hemoglobin improves energy metabolism in skeletal muscle ischemia and reperfusion in the rat.

Kurita D, Kawaguchi AT, Aso K, Yamano M, Minamitani H, Haida M.

Artif Organs. 2012 Feb;36(2):185-93. doi: 10.1111/j.1525-1594.2011.01419.x.

PMID:
22339727
37.

An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.

Miura K, Takei K, Kobayashi S, Kiso S, Hirabayashi Y, Hojo A, Kodaira H, Yagi M, Kurita D, Kobayashi Y, Tanaka T, Iriyama N, Hatta Y, Kura Y, Yamazaki T, Sawada U, Takeuchi J.

Int J Hematol. 2011 Jul;94(1):90-96. doi: 10.1007/s12185-011-0884-x. Epub 2011 Jun 23. Erratum in: Int J Hematol. 2011 Aug;94(2):218.

PMID:
21695600
38.

tRNA/mRNA Mimicry by tmRNA and SmpB in Trans-Translation.

Kurita D, Muto A, Himeno H.

J Nucleic Acids. 2011 Jan 5;2011:130581. doi: 10.4061/2011/130581.

39.

Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma.

Kobayashi Y, Miura K, Hojo A, Hatta Y, Tanaka T, Kurita D, Iriyama N, Kobayashi S, Takeuchi J.

J Cancer Res Clin Oncol. 2011 Jul;137(7):1079-84. doi: 10.1007/s00432-010-0973-x. Epub 2011 Jan 11.

PMID:
21221637
40.

[Collaboration of two kinds of tRNA/mRNA hybrids: trans-translation].

Himeno H, Kurita D, Muto A.

Tanpakushitsu Kakusan Koso. 2009 Dec;54(16 Suppl):2201-6. Review. Japanese. No abstract available.

PMID:
21089641
41.

Role of the C-terminal tail of SmpB in the early stage of trans-translation.

Kurita D, Muto A, Himeno H.

RNA. 2010 May;16(5):980-90. doi: 10.1261/rna.1916610. Epub 2010 Mar 26.

42.

Trans-translation by tmRNA and SmpB.

Une M, Kurita D, Muto A, Himeno H.

Nucleic Acids Symp Ser (Oxf). 2009;(53):305-6. doi: 10.1093/nass/nrp153.

PMID:
19749382
43.

Plasma branched-chain amino acid levels and muscle energy metabolism in patients with chronic obstructive pulmonary disease.

Kutsuzawa T, Shioya S, Kurita D, Haida M.

Clin Nutr. 2009 Apr;28(2):203-8. doi: 10.1016/j.clnu.2009.01.019. Epub 2009 Feb 27.

PMID:
19250720
44.

Liposome-encapsulated hemoglobin alleviates brain edema after permanent occlusion of the middle cerebral artery in rats.

Kawaguchi AT, Kurita D, Furuya H, Yamano M, Ogata Y, Haida M.

Artif Organs. 2009 Feb;33(2):153-8. doi: 10.1111/j.1525-1594.2008.00700.x.

PMID:
19178460
45.
46.

Molecular mechanism of trans-translation.

Kurita D, Konno T, Takada K, Muto A, Himeno H.

Nucleic Acids Symp Ser (Oxf). 2007;(51):43-4.

PMID:
18029577
47.

Interaction of SmpB with ribosome from directed hydroxyl radical probing.

Kurita D, Sasaki R, Muto A, Himeno H.

Nucleic Acids Res. 2007;35(21):7248-55. Epub 2007 Oct 24.

48.

Phosphate-related energy compounds are not exhausted in chronically hypoperfused rat brain cortex after cortical spreading depression.

Hirabayashi H, Kurita D, Takizawa S, Shinohara Y.

J Stroke Cerebrovasc Dis. 2004 Nov-Dec;13(6):271-9.

PMID:
17903987
49.

A functional interaction of SmpB with tmRNA for determination of the resuming point of trans-translation.

Konno T, Kurita D, Takada K, Muto A, Himeno H.

RNA. 2007 Oct;13(10):1723-31. Epub 2007 Aug 13.

50.

[Molecular mechanism of trans-translation].

Himeno H, Kurita D, Takada K, Konno T, Hanawa-Suetsugu K, Takemoto C, Kawazoe M, Yokoyama S, Nameki N, Kawai G, Muto A.

Seikagaku. 2007 Mar;79(3):213-21. Review. Japanese. No abstract available.

PMID:
17447495

Supplemental Content

Loading ...
Support Center